Chronimed Appoints Karen Gilles Larson to Its Board Of Directors.Business Editors/Health/Medical Writers MINNEAPOLIS--(BUSINESS WIRE)--April 30, 2003 Chronimed Inc. (Nasdaq:CHMD CHMD Change Mode Command ) announced today that Karen Gilles Larson has been appointed to its Board of Directors. Her appointment brings Chronimed's Board membership to eight directors. Ms. Larson is President and Chief Executive Officer of Synovis Life Technologies A Minneapolis based company, Synovis Life Technologies is a medical device manufacturer that recently celebrated 25 straight profitable quarters and earned itself a slot on the Fortune 100 Fastest Growing Companies and Forbes 200 Best Small Companies lists, and the Russell 2000® Index. , Inc. She joined Synovis in 1989 and held various positions, including Vice President of Finance and Chief Financial Officer, until she was appointed President and Chief Executive Officer in July, 1997. She is a Director on the Synovis board and has served as a director of Reuter Manufacturing. Ms. Larson was named by The Business Journal (Minneapolis-St. Paul) as one of the most influential women of 2002. Commenting on the new Board appointment, Chronimed's Chairman and Chief Executive Officer, Henry Blissenbach said, "We are very pleased to have Karen join our Board. Her extensive financial and healthcare experience will be an asset to Chronimed as we continue to grow our business." About Chronimed Inc. Chronimed Inc. is a disease-focused drug distribution company serving the prescription drug prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, needs of people with chronic health conditions. The Company distributes pharmaceuticals and provides specialized patient management services nationwide for people with chronic conditions such as HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome , organ transplant organ transplant: see transplantation, medical. and diseases treated with biotech injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. medications. Chronimed works directly with patients, providers, payors, manufacturers and wholesalers to improve clinical and cost-of-care outcomes. Chronimed's web site address is www.chronimed.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion